Solv Multi-Pass Hemodialysis System In-Center Clinical Study
NCT: NCT07216885 · RECRUITING
Brief Summary
Solv In-Center clinical study is a pre-market, prospective, multicenter, single arm, open-label clinical study. The patient population will include patients with kidney failure or insufficiency requiring hemodialysis and/or ultrafiltration. Eligibility will be open to incident dialysis patients and patients currently receiving HD in an in-center environment. All vascular access types including AV-fistula, AV-graft, and tunneled hemodialysis catheters.
Frequently Asked Questions
What is Solv Multi-Pass Hemodialysis System In-Center Clinical Study?
Solv Multi-Pass Hemodialysis System In-Center Clinical Study is a clinical trial registered under NCT07216885. Current status: RECRUITING.
What is the status of NCT07216885?
The current status of NCT07216885 (Solv Multi-Pass Hemodialysis System In-Center Clinical Study) is: RECRUITING.
When did Solv Multi-Pass Hemodialysis System In-Center Clinical Study start?
Solv Multi-Pass Hemodialysis System In-Center Clinical Study started on 2026-01-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.